Search
CELL BANK Website

Back Back
Cell No. : Cell Name
RCB1166 : KG-1  update : 2024/10/09
CommentHuman acute myeloid leukemia. The variant subline (RCB1928 KG-1a) CD3-,CD13+,CD14-,CD15+,CD19-,CD33+. Since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 14 prior to order.
Comment from the depositor
Terms and conditions1) There is no restriction regarding use for basic researches. However, since “Terms and conditions” etc. for this cell line can be changed, the users of this cell line must refer to ACC 14 prior to order. 2) In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC.
Remarks
Order Form Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
Basic information Depositor DSMZ
Year of deposit 1995
Animal _human < Mammals
Genus Homo
Species sapiens
Gender Male
Age at sampling 59 years
Tissue bone marrow
Disease name acute myeloid leukemia
Classification cancer
History DSMZ (ACC14)
Lifespan infinite
Morphology lymphocyte-like
Cellosaurus(Expasy) CVCL_0374
deposit info
lot info
Medium Medium List
Culture type Suspension cells
Culture method 浮遊細胞の培養に関する一般的な注意(Japanese)
Culture medium RPMI1640 + 10% FBS
Antibiotics Free
Passage method dilution
Culture information Passage ratio 1 : 10 split
SC frequency Subculture : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma/Acholeplasma (-)
Virus (HIV) LT 400
Virus (HTLV-1) (-)
Isozyme LD, NP
Chromosome mode 25-119(50) : /41(2),43(7),44(3),45(3),46(6),47(1)/
STR(human) OK
Images
deposit info
lot info
Reference information Reference 4
User's Publication 19


To topTop
Reference
2219  Konishi K, Tanabe F, Taniguchi M, Yamauchi H, Tanimoto T, Ikeda M, Orita K, Kurimoto M  A simple and sensitive bioassay for the detection of human interleukin-18/interferon-gamma-inducing factor using human myelomonocytic KG-1 cells.  J Immunol Methods  1997  209:187-91  PubMed ID: 9461334   DOI: 10.1016/s0022-1759(97)00164-6
880  Koeffler, H P  Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications.  Blood  1983  62:709-21  PubMed ID: 6192859  
1937  Koeffler, H P, Golde, D W  Human myeloid leukemia cell lines: a review.  Blood  1980  56:344-50  PubMed ID: 6996765  
625  Koeffler, H P, Golde, D W  Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity.  Science  1978  200:1153-4  PubMed ID: 306682   DOI: 10.1126/science.306682

To topTop
User's Publication
21628  Kawakatsu R, Tadagaki K, Yamasaki K, Yoshida T.  Venetoclax efficacy on acute myeloid leukemia is enhanced by the combination with butyrate.  Sci Rep  2024  14(1):4975  PubMed ID: 38424468   DOI: 10.1038/s41598-024-55286-0
20451  Phan TKT, Do TL, Tachibana K, Kihara T.  Alpha-mangostin dephosphorylates ERM to induce adhesion and decrease surface stiffness in KG-1 cells.  Hum Cell  2022    PubMed ID: 34817798   DOI: 10.1007/s13577-021-00651-8
16047  Kihara T, Matsumoto T, Nakahashi Y, Tachibana K.  Mechanical stiffness softening and cell adhesion are coordinately regulated by ERM dephosphorylation in KG-1 cells  Hum Cell  2021  34(6):1709-1716  PubMed ID: 34312810   DOI: 10.1007/s13577-021-00584-2
11953  Tachibana K, Ohnishi H, Ali Haghparast SM, Kihara T, Miyake J.  Activation of PKC induces leukocyte adhesion by the dephosphorylation of ERM.  Biochem. Biophys. Res. Commun.  2020    PubMed ID: 31843195   DOI: 10.1016/j.bbrc.2019.12.044
14832  Saito S, Kitamura-Muramatsu Y, Komine F, Polat M, Takeshima SN, Takei M, Aida Y.  Absence of bovine leukemia virus proviral DNA in Japanese human blood cell lines and human cancer cell lines  Arch Virol  2020  165(1):207-214  PubMed ID: 31776677   DOI: 10.1007/s00705-019-04474-9
12516  Ono M, Takimoto R, Osuga T, Okagawa Y, Hirakawa M, Yoshida M, Arihara Y, Uemura N, Hayasaka N, Miura S, Matsuno T, Tamura F, Sato Y, Sato T, Iyama S, Miyanishi K, Takada K, Kobune M, Kato J.  Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin  Oncotarget  2016  7(25):38586-38597  PubMed ID: 27233074   DOI: 10.18632/oncotarget.9558
16179  Koya J, Kataoka K, Sato T, Bando M, Kato Y, Tsuruta-Kishino T, Kobayashi H, Narukawa K, Miyoshi H, Shirahige K, Kurokawa M.  DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation  Nat Commun  2016  7:1092  PubMed ID: 27010239   DOI: 10.1038/ncomms10924
19156  Miyuki Kumano-Kuramochi  Lectin-Like Oxidized LDL Receptor 1 Mediates the Uptake of the C-Terminal Domain of Hsp70 (A Promising Immune Adjuvant Molecule) and Antigen Peptide Complexes  International Journal of Biochemistry Research & Review  2014  4:284-294    DOI: 10.9734/ijbcrr/2014/8699
6082  Ohnishi H, Sasaki H, Nakamura Y, Kato S, Ando K, Narimatsu H, Tachibana K.  Regulation of cell shape and adhesion by CD34  Cell Adh Migr  2013  7(5):426-33  PubMed ID: 24036614   DOI: 10.4161/cam.25957
15792  Kon A, Shih LY, Minamino M, Sanada M, Shiraishi Y, Nagata Y, Yoshida K, Okuno Y, Bando M, Nakato R, Ishikawa S, Sato-Otsubo A, Nagae G, Nishimoto A, Haferlach C, Nowak D, Sato Y, Alpermann T, Nagasaki M, Shimamura T, Tanaka H, Chiba K, Yamamoto R, Yamaguchi T, Otsu M, Obara N, Sakata-Yanagimoto M, Nakamaki T, Ishiyama K, Nolte F, Hofmann WK, Miyawaki S, Chiba S, Mori H, Nakauchi H, Koeffler HP, Aburatani H, Haferlach T, Shirahige K, Miyano S, Ogawa S.  Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms  Nat Genet  2013  45(10):1232-7  PubMed ID: 23955599   DOI: 10.1038/ng.2731
7886  Saito Y, Nakahata S, Yamakawa N, Kaneda K, Ichihara E, Suekane A, Morishita K.  CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression.  Leukemia  2011  25:921-31  PubMed ID: 21394097   DOI: 10.1038/leu.2011.36
8778  Keiko Fukushima and Katsuko Yamashita  Carbohydrate Recognition by Cytokines and Its Relevance to Their Physiological Activities  Experimental Glycoscience  2008  154-157   
5983  Nemoto N, Suzukawa K, Shimizu S, Shinagawa A, Takei N, Taki T, Hayashi Y, Kojima H, Kawakami Y, Nagasawa T.  Identification of a novel fusion gene MLL-MAML2 in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23).  Genes Chromosomes Cancer  2007  46(9):813-9  PubMed ID: 17551948   DOI: 10.1002/gcc.20467
6144  Ninomiya M, Abe A, Katsumi A, Xu J, Ito M, Arai F, Suda T, Ito M, Kiyoi H, Kinoshita T, Naoe T.  Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice.  Leukemia  2007  21(1):136-42  PubMed ID: 17039228   DOI: 10.1038/sj.leu.2404432
8818  Matsumoto E, Hatanaka M, Bohgaki M, Maeda S.  PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells.  Kobe J Med Sci  2006  52:181-94  PubMed ID: 17329956  
3335  Yoshino K, Iimura E, Saijo K, Iwase S, Fukami K, Ohno T, Obata Y, Nakamura Y.  Essential role for gene profiling analysis in the authentication of human cell lines.  Hum Cell  2006  19(1):43-8  PubMed ID: 16643607   DOI: 10.1111/j.1749-0774.2005.00007.x
2974  Tamura H, Dan K, Tamada K, Nakamura K, Shioi Y, Hyodo H, Wang SD, Dong H, Chen L, Ogata K  Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia  Clin Cancer Res  2005  15:5708-5717  PubMed ID: 16115907   DOI: 10.1158/1078-0432.CCR-04-2672
2913  Fukushima K, Ikehara Y, Yamashita K  Functional role played by the glycosylphosphatidylinositol anchor glycan of CD48 in interleukin-18-induced interferon-gamma production.  J Biol Chem  2005  280:18056-62  PubMed ID: 15760905   DOI: 10.1074/jbc.M413297200
5943  Rumi MA, Sato H, Ishihara S, Ortega C, Kadowaki Y, Kinoshita Y.  Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands.  J Lab Clin Med  2002  140(1):17-26  PubMed ID: 12080324   DOI: 10.1067/mlc.2002.125055



Back Back Return Top Page